Rim Plate to Buttress Plate for Posterior Wall Acetabular Fractures With and Without Inter-fragmentary Screws

May 7, 2024 updated by: H. Claude Sagi, MD, University of Cincinnati

A Randomized Prospective Study Comparing Rim Plate to Buttress Plate for Posterior Wall Acetabular Fractures With and Without Inter-fragmentary Screws

The hypothesis of this study is that the Rim Plate method utilizing interfragmentary screws placed through the plate will result in superior fixation, a lower rate of loss of reduction of the fracture fragment, better anatomic healing of the articular (joint) surface, a decreased rate of early post-traumatic arthritic changes of the joint (cartilage) surface, and improved functional outcomes.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Study type: Interventional Estimated enrollment: 60 Allocation: block randomization. The block randomization method is designed to randomize subjects into groups that result in equal sample sizes. This method is used to ensure a balance in sample size across groups over time.

Interventional model: parallel assignment Description: two different methods of screw and plate fixation of posterior wall acetabulum fractures.

Time perspective: Prospective

Population:

Skeletally mature patients who have presented with an acute traumatic fracture of the posterior wall of acetabulum due to dislocation of the femoral head will be included in this study. All surgeons on the study routinely perform both types of repairs.

Treatment arms and Intervention:

Arm A: Rim plate group - This group will consist of 30 patients where the posterior wall fracture will be operatively stabilized with a pelvic reconstruction plate and interfragmentary screws placed through the plate.

Arm B: Buttress plate group - This group will consist of 30 patients where the posterior wall fracture will be operatively fixed with a buttress plate applied under compression without interfragmentary lag or position screws.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Kimberly A Hasselfeld
  • Phone Number: 5135581933
  • Email: hasselky@uc.edu

Study Locations

    • Ohio
      • Cincinnati, Ohio, United States, 45267
        • Recruiting
        • University of Cincinnati College of Medicine
        • Contact:
        • Principal Investigator:
          • Henry C Sagi, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Skeletally mature males and females, ≥ 18 years old and with age less than 65 years.
  2. Fracture of the acetabular posterior wall fracture due to acute traumatic hip dislocation, confirmed with anteroposterior pelvic or hip radiographs, and CT scan
  3. Operative fixation of fractures within 14 days of presenting to the emergency room.
  4. Patient was ambulatory prior to fracture, with or without walking aids
  5. Medically optimized for operative intervention
  6. Provision of informed consent by patient or legal guardian.

Exclusion Criteria:

  1. Patients not suitable for internal fixation (severe osteoarthritis, rheumatoid arthritis, or pathologic fracture).
  2. Pre-existing orthopedic fixation, implant, or prosthesis around the affected acetabulum.
  3. Patients with metabolic bone disease including diagnosis of osteoporosis.
  4. Patients with bony or soft tissue infections around the acetabulum.
  5. Patients unable to provide informed consent.
  6. Patients having other fractures of Pelvis or acetabulum other than an isolated posterior acetabular wall fracture.
  7. Patients with previous history of acetabular fracture (operative or nonoperative)
  8. Patients with previous history of hip pathology such as avascular necrosis, hip dysplasia, Legg-Calve Perthes Disease, or advanced degenerative arthritis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Rim plate group
This group will consist of 30 patients where the posterior wall fracture will be operatively stabilized with a pelvic reconstruction plate and interfragmentary screws placed through the plate.
interfragmentary screws placed through the plate or buttress plate applied under compression without interfragmentary lag or position screws
Other Names:
  • interfragmentary screws placed through the plate
  • buttress plate applied under compression without interfragmentary lag or position screws
Other: Buttress plate group
This group will consist of 30 patients where the posterior wall fracture will be operatively fixed with a buttress plate applied under compression without interfragmentary lag or position screws.
interfragmentary screws placed through the plate or buttress plate applied under compression without interfragmentary lag or position screws
Other Names:
  • interfragmentary screws placed through the plate
  • buttress plate applied under compression without interfragmentary lag or position screws

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Displacement of posterior wall acetabular fragment
Time Frame: 12 months
Measured on immediate post-op CT and compared to measurement one year post-op
12 months
Healing of the posterior wall fragment
Time Frame: 12 months
Measured on immediate post-op CT and compared to measurement one year post-op
12 months
Articular space loss
Time Frame: 12 months
Degree and extent of articular space loss (chondrolysis)
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Merle d'Aubigne score
Time Frame: 12 months
Evaluates pain, gait and mobility
12 months
IOWA hip score
Time Frame: 12 months
Hip rating system
12 months
PROMIS-10 score
Time Frame: 12 months
A system of highly reliable, precise measures of patient-reported health status for physical, mental, and social well-being
12 months
SMFA score
Time Frame: 12 months
Measure the functional status of patients with a broad range of musculoskeletal injuries and disorders
12 months
SF 36 score
Time Frame: 12 months
Quantifies health status and measures health-related quality of life
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2023

Primary Completion (Estimated)

March 1, 2025

Study Completion (Estimated)

March 1, 2026

Study Registration Dates

First Submitted

May 7, 2024

First Submitted That Met QC Criteria

May 7, 2024

First Posted (Actual)

May 10, 2024

Study Record Updates

Last Update Posted (Actual)

May 10, 2024

Last Update Submitted That Met QC Criteria

May 7, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • OS22025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acetabular Fracture

Clinical Trials on pelvic reconstruction

3
Subscribe